Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs?

We report a successful case of living-donor lobar lung transplantation (LDLLT) for therapy-resistant broncho-bronchiolitis obliterans (BBO) after allogeneic hematopoietic stem cell transplantation (HSCT). Bronchiolitis obliterans (BO) is one of the late-onset noninfectious pulmonary complications that occur after allogeneic HSCT and is usually resistant to immunosup-pressive therapy. A 17-year-old girl with acute lymphoblastic leukemia (ALL) had undergone allogeneic bone marrow transplantation (BMT) from an HLA-matched sibling in 1997. Five years later, she relapsed with ALL and was treated with chemotherapy following stem cell rescue and donor lymphocyte infusion from the original BMT donor. Eight months later, BBO resistant to immunosuppressive therapies, including rituximab, developed in combination with chronic graft-versus-host disease (GVHD). In February 2004, the patient underwent LDLLT from 2 other family members who were mismatched at 3 HLA loci. The patient has been in good health for more than 30 months following LDLLT and shows no sign of BBO in the transplanted lungs, just as with other patients who have undergone lung transplantation for BO associated with chronic GVHD. LDLLT may therefore be considered a viable therapeutic option for the treatment of BO after allogeneic HSCT.

[1]  A. Yim,et al.  Bronchiolitis obliterans following lung transplantation. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[2]  S. Mineishi,et al.  Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning , 2005, Bone Marrow Transplantation.

[3]  M. Aoe,et al.  Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation. , 2005, The Annals of thoracic surgery.

[4]  S. Palmer,et al.  Living-related lobar lung transplantation. , 2004, Journal of cardiothoracic and vascular anesthesia.

[5]  C. Nakaseko,et al.  Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. , 2003, Blood.

[6]  D. Weisdorf,et al.  Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  M. Becker,et al.  Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  T. Kyo,et al.  Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study , 2002, Leukemia.

[9]  T. Spray,et al.  Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience. , 2001, Transplantation.

[10]  B. Afessa,et al.  Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation , 2001, Bone Marrow Transplantation.

[11]  C. Herold,et al.  SUCCESSFUL LUNG TRANSPLANTATION FOR BRONCHIOLITIS OBLITERANS AFTER ALLOGENEIC MARROW TRANSPLANTATION , 2001, Transplantation.

[12]  S. Shapiro,et al.  Lung transplantation in children following treatment for malignancy. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  H. Heimpel,et al.  Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome , 2000, Bone Marrow Transplantation.

[14]  S. Swensen,et al.  Late‐onset noninfectious pulmonary complications after allogeneic bone marrow transplantation , 1998, British journal of haematology.

[15]  T. Tsuzuki,et al.  Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases , 1997, Virchows Archiv.

[16]  T. Kyo,et al.  Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. , 1996, Blood.

[17]  S. Yousem.  The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. , 1995, Human pathology.

[18]  E. Archimbaud,et al.  Post-transplant obstructive lung disease ("bronchiolitis obliterans"): a clinical comparative study of bone marrow and lung transplant patients. , 1995, The European respiratory journal.

[19]  A. Svejgaard,et al.  Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow. , 1995, Transplantation proceedings.

[20]  S. Boas,et al.  Pediatric lung transplantation for graft-versus-host disease following bone marrow transplantation. , 1994, Chest.

[21]  J. Calhoon,et al.  Lung transplantation in a patient with a prior bone marrow transplant. , 1992, Chest.

[22]  A. Patchefsky,et al.  Bronchiolitis obliterans after autologous bone marrow transplantation. , 1992, Chest.

[23]  R. Hyland,et al.  Pulmonary complications following bone marrow transplantation. , 1990, Clinics in chest medicine.

[24]  K. Sullivan,et al.  Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. , 1989, Annals of internal medicine.

[25]  J. Wingard,et al.  Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. , 1988, Blood.

[26]  E. Rosenow,et al.  Pulmonary complications of bone marrow transplantation. , 1985, Chest.

[27]  S. Yousem,et al.  Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. , 1984, Chest.

[28]  M. D. Robbin G. Cohen,et al.  Living Donor Lung Transplantation , 2001, World Journal of Surgery.

[29]  A. Gascoigne,et al.  Lung transplants in patients with prior bone marrow transplants. , 1994, Chest.

[30]  A. Patchefsky,et al.  Bronchiolitis obliterans after bone marrow transplantation: the effect of preconditioning. , 1993, Respiration; international review of thoracic diseases.

[31]  E. Bücherl.  [Clinical status of lung transplantation]. , 1971, Deutsches medizinisches Journal.